Improving diabetes care and education of latinos: A challenging but important mission A. Enrique Caballero Invited Commentary 04 October 2007 Pages: 321 - 323
Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers Anthony L. McCall Clinical Trials Report 04 October 2007 Pages: 329 - 332
Who should benefit from the use of alpha-glucosidase inhibitors? Ariane GodboutJean-Louis Chiasson OriginalPaper 04 October 2007 Pages: 333 - 339
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors Bo Ahrén OriginalPaper 04 October 2007 Pages: 340 - 347
Which basal insulin should be used in patients with type 2 diabetes mellitus? John N. CloreLinda Thurby-Hay OriginalPaper 04 October 2007 Pages: 348 - 352
How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk? Peter E. H. SchwarzJiang LiJaakko Tuomilehto OriginalPaper 04 October 2007 Pages: 353 - 362
Selection and education of patients for inhaled insulin Srikanth BellaryAnthony H. Barnett OriginalPaper 04 October 2007 Pages: 363 - 368
Exenatide and rimonabant: New treatments that may be useful in the management of diabetes and obesity Jennifer B. GreenMark N. Feinglos OriginalPaper 04 October 2007 Pages: 369 - 375
Diabetes self-management education and third-party reimbursement: What are the options? Joan V. Czarnowski-Hill OriginalPaper 04 October 2007 Pages: 381 - 385
The use of motivational interviewing in weight loss Brent Van Dorsten OriginalPaper 04 October 2007 Pages: 386 - 390
Cultural approaches to diabetes self-management programs for the Latino community Andreina Millan-FerroA. Enrique Caballero OriginalPaper 04 October 2007 Pages: 391 - 397
